Staar Surgical Board Authorizes $50M Share Repurchase Program
Question
Staar Surgical Board Authorizes $50M Share Repurchase Program
Direct answer
Staar Surgical's board approved an authorization permitting up to $50 million in equity buybacks. Management cited internal balance sheet health and current market mispricing relative to cash-generation capability. The stock responded with an immediate 7.5% advance. The buyback provides downside price support, though real EPS accretion will depend on the cadence of open-market repurchases over the next two quarters. — bullish pressure on STAA.
- Original publisher
- Market Ontology
- Evidence through
- 2026-09-26
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Staar Surgical Board Authorizes $50M Share Repurchase Program”, revision 1, evidence through 2026-09-26. https://marketontology.com/catalysts/2026-09-26/staar-surgical-board-authorizes-50m-share-repurchase-program-1f9c47
| Asset | Direction | Timeframe | Channel | Score |
|---|---|---|---|---|
| STAA | ▲Bull | 1–4 weeks | Catalyst Driven | 72 |
Staar Surgical Board Authorizes $50M Share Repurchase Program
Staar Surgical's board approved an authorization permitting up to $50 million in equity buybacks. Management cited internal balance sheet health and current market mispricing relative to cash-generation capability. The stock responded with an immediate 7.5% advance. The buyback provides downside price support, though real EPS accretion will depend on the cadence of open-market repurchases over the next two quarters. — bullish pressure on STAA.
Staar Surgical's board approved an authorization permitting up to $50 million in equity buybacks. Management cited internal balance sheet health and current market mispricing relative to cash-generation capability. The stock responded with an immediate 7.5% advance. The buyback provides downside price support, though real EPS accretion will depend on the cadence of open-market repurchases over the next two quarters.
- SummaryStaar Surgical's board approved an authorization permitting up to $50 million in equity buybacks. Management cited internal balance sheet health and current market mispricing relative to cash-generation capability. The stock responded with an immediate 7.5% advance. The buyback provides downside price support, though real EPS accretion will depend on the cadence of open-market repurchases over the next two quarters.
- STAADirect directional exposure
Illustrative, not advice
- Crowded positioning may already reflect the move
- Counter-catalyst could neutralize the thesis before window closes
- STAA closes below pre-catalyst level on rising volume
- Catalyst narrative is officially walked back or contradicted
- Cross-asset confirmation (rates / FX / vol) reverses direction
- STAA price vs. pre-event level
- STAA volume vs. 20-day average
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| STAA | Bullishagreed | 20.51 2026-09-25 | +1.76% | +9.56% | Pending |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related catalysts
- 2026-09-30Staar Surgical Rallies 8% Following Stifel Upgrade to Buy and $31 TargetSF STAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% on Stifel Upgrade and Lens Demand OutlookSTAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% on Stifel Rating Upgrade and Higher Price TargetSTAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% on Stifel Rating Upgrade and Higher Price TargetSTAA-1.11%
- 2026-09-27Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback ProgramSTAA+9.56%
- 2026-09-27Staar Surgical Board Authorizes $50 Million Share Repurchase ProgramSTAA+9.56%
- 2026-09-27Staar Surgical initiates $50M share repurchase program, lifting stock 7.5%STAA+9.56%
- 2026-09-27Staar Surgical Board Authorizes $50 Million Share Buyback ProgramSTAA+9.56%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.